Zetafen

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Zetafen

Zetafen is a commercial brand name for a pharmaceutical product whose active ingredient is Ibuprofen. It is defined as a single-ingredient product used to provide relief from pain, fever, and inflammation, and it is scientifically categorized as a Nonsteroidal Anti-Inflammatory Drug (NSAID).


Property Description
Active ingredient Ibuprofen
Form Tablet, Caplet, or Capsule (Oral)
Pharmacological class Nonsteroidal Anti-Inflammatory Drug (NSAID)
General use Relief of pain, fever, and inflammation
Origin Synthetic (Propionic Acid Derivative)

What Type of Medicine is Zetafen?

Zetafen belongs to the Nonsteroidal Anti-Inflammatory Drug (NSAID) pharmacological class, a category identified among essential medicines. Ibuprofen, its active constituent, is structurally classified as a propionic acid derivative. The Ibuprofen compound is synthetic, meaning it is manufactured chemically rather than being derived from natural sources. This NSAID classification is clinically recognized for its efficacy in mitigating pain and inflammation.

Composition and Physical Form

Zetafen’s core component is the active ingredient, Ibuprofen, which is combined with necessary excipients to create the final preparation. Ibuprofen is generally presented as a racemic mixture of two molecular structures, the R- and S-enantiomers; the S-enantiomer is primarily responsible for the therapeutic activity. The product is most often formulated in solid dosage forms such as a tablet, caplet, or capsule, designed for oral administration.

What is Zetafen’s General Purpose?

Zetafen's general purpose is to provide simultaneous analgesic (pain relief), antipyretic (fever reduction), and anti-inflammatory effects within the body. Its use is typical in scenarios like relieving general discomfort associated with common headaches or muscular aches. This three-pronged action stems from its established function as a non-selective cyclooxygenase (COX) inhibitor, which reduces the creation of prostaglandins—chemical messengers that mediate pain and inflammation—thereby offering broad symptomatic relief.

Regulatory References

  1. NIH/MedlinePlus

What side effects are possible with Zetafen?

Possible Side Effects and Safety Information

Serious Adverse Reactions and Warnings

Zetafen has been associated with a risk of severe liver injury, including cases of acute liver failure requiring transplant or resulting in death. This risk is primarily linked to exceeding the maximum recommended daily dose or consuming other products containing the same active ingredient.

Regulatory agencies also require warnings for rare but serious skin reactions (Severe Cutaneous Adverse Reactions or SCARs), such as Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN). These conditions are potentially fatal. If skin reddening, rash, blisters, or peeling occurs, the medication should be discontinued immediately.

Common Adverse Reactions

When taken at recommended therapeutic doses, Zetafen is generally well-tolerated. However, common adverse reactions affecting various system-organ classes have been documented in regulatory reports. These may include Gastrointestinal disorders such as nausea and vomiting, as well as Nervous System disorders like headache and dizziness. Increased levels of liver enzymes have also been reported, which can be a sign of hepatic stress.

Safety Considerations

The risk of severe liver damage is dose-dependent. Caution is advised for patients with pre-existing liver disease or those who consume three or more alcoholic drinks daily, as these factors may increase the risk of hepatotoxicity. Use in the pediatric population requires strict adherence to weight-based dosing. The product is contraindicated in individuals with a known severe hypersensitivity or allergy to the active ingredient.

Overdose and Emergency Response

Overdose and when to seek help

The most severe risk associated with Zetafen overdose is fatal hepatic necrosis (severe liver damage). Overdose may occur from taking a single large dose or from repeated use exceeding the maximum daily limits, often by combining multiple products containing the substance.


Documented Overdose Symptoms

Initial signs of an overdose are typically nausea, vomiting, diaphoresis (sweating), and a general feeling of malaise. Symptoms related to severe liver damage may be delayed, often not appearing until 24 to 48 hours after ingestion, and may include pain or tenderness in the upper right side of the abdomen.

Individuals with specific risk factors, such as those with a history of chronic alcohol use, may be at a greater risk for hepatotoxicity following an overdose.


Required Emergency Action

Immediate medical attention is required if an overdose is suspected, even if no symptoms are present. Do not wait for initial symptoms to subside. Contact a Poison Control Center or emergency medical services right away.

Official regulatory guidelines emphasize that prompt treatment is critical. Medical professionals initiate specific management procedures, which can include the administration of an antidote (e.g., N-acetylcysteine) and supportive care, based on the dose taken and the measured concentration of the substance in the blood. Delaying treatment significantly increases the risk of severe and potentially fatal outcomes.

Therapeutic Uses of Zetafen

What Zetafen treats: main uses and benefits

Zetafen is generally applied across domains where additional symptomatic support is needed, focusing on symptoms related to physical discomfort and systemic imbalance. It is commonly used across conditions characterized by episodic or fluctuating symptom manifestations.

The medication is considered relevant for managing symptoms associated with acute episodes, including those related to physical discomfort like headaches, backaches, sprains or strains, and specific pain such as menstrual cramps and toothache.

It is often used during phases when symptoms create noticeable interference with daily functioning, and may provide support that helps ease the overall symptom burden. In chronic settings, it may assist with managing the sustained discomfort of conditions like Rheumatoid Arthritis and Osteoarthritis.

It is also commonly used when symptoms become more noticeable in clinical settings marked by increased discomfort from fever and associated systemic aches, which may assist with maintaining functional stability.


Quick Fact: Easing Symptoms Related to Pain, Fever, and Inflammation

Zetafen is commonly used to help with short-term symptom management, assisting with symptomatic relief of mild to moderate pain and easing elevated body temperature associated with systemic imbalance.

Eligibility and Restrictions for Use

Who Can and Cannot Use Zetafen?

The population eligibility for Zetafen (Ibuprofen) is determined by regulatory agencies based on age, physiological state, and pre-existing medical conditions.

Populations Contraindicated (Must Not Use)

Use is strictly contraindicated for patients with a known hypersensitivity or allergy to NSAIDs (such as aspirin), in the setting of severe heart failure, severe renal failure, or severe hepatic failure, and when active gastrointestinal bleeding or ulceration is present. The medicine must not be used by patients recovering from Coronary Artery Bypass Graft (CABG) surgery or during the last trimester of pregnancy (ge 30 weeks gestation).

Age-Related Eligibility

Age Group Eligibility Status Restrictions/Caution
Infants Not established/Contraindicated Generally not recommended for children under 6 months of age.
Children/Adolescents Allowed Use is established, but some solid dosage forms may be contraindicated for children under 6 years or < 20 kg body weight.
Older Adults (ge 60) Restricted Use Use requires caution due to increased risk of serious adverse events; the lowest effective dose should be used.

Conditional Use and Restrictions

Use requires caution and monitoring in patients with a prior history of gastrointestinal ulcers, hypertension, pre-existing heart failure (NYHA Class II-III), or mild to moderate renal/hepatic impairment.

What should I know about interactions with other medicines?

Interactions with other medicines and products

This section describes the officially documented interaction patterns for Zetafen (Ibuprofen) as defined in government regulatory labeling.


Formal Contraindicated Combinations

Regulatory documents strictly prohibit co-administration with:

  • Other Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): Including cyclooxygenase-2 (COX-2) selective inhibitors, due to an additive pharmacodynamic risk of gastrointestinal bleeding or ulceration.
  • High-Dose Acetylsalicylic Acid (Aspirin): Doses above 75 mg per day are contraindicated due to increased adverse reaction risk.
  • Other Paracetamol-containing products: Co-administration is prohibited due to the risk of serious adverse effects.

Documented Exposure and Pharmacodynamic Interactions

Zetafen enters into interactions that alter drug exposure or produce additive effects. The co-administration of anticoagulants (such as Warfarin) or antiplatelet agents (including SSRIs) significantly enhances the risk of gastrointestinal bleeding.

Lithium and Methotrexate clearance may be reduced, resulting in increased plasma levels of these co-administered medicines due to decreased renal elimination. Ibuprofen may also reduce the anti-hypertensive and diuretic effects of agents like ACE inhibitors and Beta-blockers.

Timing and Substance Constraints

To prevent the competitive inhibition of the cardioprotective effect of low-dose Aspirin, specific timing separation is required: Ibuprofen must be taken at least 8 hours before or at least 30 minutes after the immediate-release Aspirin dose. Additionally, heavy or chronic alcohol consumption increases the documented risk of serious gastrointestinal bleeding.

Mechanism of Action

️ How Zetafen Works: Mechanism of Action

Zetafen (Ibuprofen) modulates the activity of physiological pathways by acting as a non-selective, competitive inhibitor of the Cyclooxygenase (COX) enzyme. This molecular action targets and modifies early steps in a key signaling cascade that shapes systemic physiological outcomes, resulting in alterations of nociceptive, inflammatory, and central thermoregulatory signaling.


Modulating the Arachidonic Acid Cascade

This domain covers the drug's primary biological targets: the COX-1 and COX-2 enzymes. Ibuprofen reversibly blocks these enzymes, which stops the synthesis of Prostaglandins (PGE2) and other eicosanoids that act as pro-inflammatory mediators. The resulting physiological effect is a decreased concentration of chemical signals that modulate vascular permeability and afferent nerve fiber sensitivity.


Central Regulation of Temperature and Nociception

This mechanistic domain involves the drug's effect across the Central Nervous System (CNS) and peripheral nociceptive pathways. By suppressing PGE2 synthesis in the hypothalamus, the drug influences the activity of processes driven by distinct signaling patterns, causing the re-establishment of the elevated thermoregulatory set-point. The reduction of PGE2 also reduces the responsiveness of peripheral pain fibers.

Dosage and Administration Information

Instruction Map: How to use Zetafen — Official Administration Guidelines

Administration Scope

Label Entity Instruction
Route of administration Zetafen is typically administered orally via tablets, capsules, or suspension. An intravenous (IV) solution is an option for use in appropriate clinical settings.
Dosing schedule For short-term use, the adult dose is generally 200 mg to 400 mg, with a maximum daily intake of 1200 mg for non-prescription forms, or up to 3200 mg for certain prescription regimens in divided doses.
Timing in relation to meals The medicine may be taken with food or milk to reduce the potential for gastrointestinal discomfort.
Preparation requirements Oral liquid suspensions must be shaken well before measuring a dose. The intravenous solution requires dilution before administration as an infusion.
Age-group administration rules Older adults are instructed to use the lowest effective dose for the shortest duration. Pediatric dosing is generally based on the patient's weight or age, with specific maximum limits and is not advised for infants under six months without professional guidance.
Missed-dose rules If a scheduled dose is missed, the subsequent dose should be taken at the next regularly scheduled time, without taking a double dose to compensate.
Special procedural conditions The core principle of use is to utilize the lowest effective dose for the shortest duration necessary. The minimum interval between doses is typically 4 to 6 hours. IV administration must be performed by qualified professionals as an infusion over 30 minutes.

Instruction Classifications (High-Level)

Classification Pattern
Administration method type Oral, Intravenous (IV).
Frequency pattern As-needed (short-term), Divided daily (chronic).
Regulatory basis Standardized clinical protocols and health frameworks.
Use-context constraints Treatment duration is limited for short-term use (e.g., generally not more than 10 days for pain).

Resulting procedural structure

Official step sequence:

  • The appropriate dosage (200 mg to 800 mg) is determined based on the condition being addressed and in alignment with established clinical protocols.
  • The oral dose is administered, with the option of taking it with food or milk if desired.
  • Repeat doses must be separated by a minimum time interval (e.g., 4 to 6 hours), ensuring the maximum daily limit is not exceeded.

Connection to the overall use protocol These instructions establish the standardized framework for administering Zetafen, detailing the official route of intake, the defined dosage limits, the necessary time spacing between doses, and the mandatory duration limits for short-term use. This collective guidance ensures the medicine is used according to precise procedures documented for clinical consistency.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Zetafen


The following overview summarizes the types of official research, including clinical trials and systematic reviews, that have examined the active ingredient in Zetafen, Ibuprofen, and the study outcomes researchers have explored, without offering clinical advice or recommendations.

Evidence for Use in Acute Mild to Moderate Pain

Research exploring how symptoms change over time in acute pain relies heavily on numerous short-term Randomized Controlled Trials (RCTs). These studies was studied for evaluating Ibuprofen in patients experiencing acute episodes of discomfort, such as pain following dental procedures or muscular aches. The trials generally monitored outcomes related to physical discomfort.

Studies focusing on episodes where symptoms become more noticeable reported measurements related to the timing and magnitude of perceived discomfort changes. The weight of the evidence is concentrated on the immediate, short-term changes observed in controlled trial settings, but research does not determine whether an individual will respond similarly.

Evidence for Antipyretic Use (Fever Reduction)

Research examining temporary physiological imbalance due to fever was studied for both adults and children. This evidence is primarily based on Randomized Controlled Trials (RCTs) and associated systematic reviews that compared Ibuprofen against placebo and other studied antipyretic agents. The trials monitored outcomes reflecting physiological strain, specifically evaluating objective measurements of change in body temperature from the baseline reading.

In studies involving comparisons, findings were mixed in some trials regarding the duration and magnitude of the temperature change. Evidence is limited for use in populations with underlying complex or high-risk systemic diseases.


Evidence for Long-Term Symptomatic Management in Chronic Conditions

For chronic conditions like Osteoarthritis and Rheumatoid Arthritis, research was observed in studies observing responses over defined time intervals. This required using intermediate-to-long-term RCTs alongside large-scale observational settings evaluating daily-life functioning. Studies explored outcomes reflecting daily functioning or activity level.

This area highlights a critical consideration: while symptomatic changes were monitored, the risk profile, including co-occurring systemic risks, was observed in some studies to increase with the duration of administration. There is limited information for long-term outcomes on effects beyond one year, and the research does not determine effects on the underlying progression of the disease.

Key Limitations and Areas of Research Uncertainty

Evidence quality varies across studies, and findings were mixed in some trials comparing the active agent to other studied agents. Long-term effects are not fully established regarding continuous use over many years. Additionally, evidence exploring certain subgroups and pain types data are still emerging, meaning subgroup findings are uncertain.

Key Studies & References Osteoarthritis: care and management (National Institute for Health and Care Excellence - NICE Guideline)

Frequently Asked Questions (FAQ)

Common questions about Zetafen (FAQ)


Q: What is the main difference between Zetafen and other similar medicines?

According to official product information, Zetafen’s active ingredient, Ibuprofen, is classified as a Nonsteroidal Anti-Inflammatory Drug (NSAID). It works primarily by non-selectively blocking two enzymes, COX-1 and COX-2, to reduce the creation of chemical messengers called prostaglandins. This specific molecular action and drug classification distinguish it from pain relievers in other pharmacological classes, such as those based on acetaminophen.


Q: Do I need a prescription to get Zetafen?

Regulatory labeling confirms that Zetafen is available in different forms and strengths. Lower doses of the medicine are obtainable in non-prescription (over-the-counter) forms. However, certain higher doses or specialized forms are classified as prescription-only and require authorization from a healthcare professional.


Q: Is there a generic version of Zetafen available yet?

Yes. Since Zetafen’s active ingredient is Ibuprofen, which is off-patent, many different generic versions of the medicine are widely available. These generic products contain the same active ingredient as the brand-name product.


Q: How quickly does Zetafen start working after taking it?

Official clinical pharmacology information states that the pain-relieving effects of Zetafen typically begin working within one hour of oral administration. However, the precise onset time can vary based on the specific condition being treated and the person taking the medicine.


Q: What are common patient misunderstandings about how Zetafen works?

Patient education materials from health authorities frequently highlight misunderstandings related to the medicine’s use. These often involve confusion over the maximum daily dose, the need to avoid co-administration with other NSAIDs (like naproxen), and underestimation of the potential for serious side effects like gastrointestinal bleeding.


Q: Does Zetafen have a 'black box warning'?

Yes, the FDA requires a Boxed Warning (often referred to as a 'black box warning') on the labeling for Zetafen. This warning highlights the increased risk of serious cardiovascular thrombotic events and serious gastrointestinal adverse events (including bleeding or ulceration).


Q: Can Zetafen cause any long-term health problems?

Official warnings note that the risk of serious side effects, including gastrointestinal bleeding and cardiovascular events, is observed to increase with the duration of use and with higher doses. Regulatory guidance notes that the lowest effective dose for the shortest duration necessary is the principle of use.


Q: Is it normal to feel tired or drowsy when first taking Zetafen?

Regulatory adverse reactions sections list drowsiness (somnolence) and lethargy as reported, though typically less common, side effects. Official information notes that dizziness is listed as a common reaction that can affect alertness.


Q: How does Zetafen affect driving or operating machinery?

Since Zetafen can cause side effects such as dizziness, drowsiness, or visual disturbances, regulatory information advises caution. If these effects occur, regulatory information notes that avoiding driving or operating machinery is recommended.


Q: Is Zetafen considered a habit-forming or addictive drug?

No, Zetafen is not classified as a narcotic or controlled substance by regulatory agencies. Official fact sheets confirm that it is not considered addictive or habit-forming in the medical sense of physical dependence.


Q: What happens if I stop taking Zetafen suddenly?

Regulatory documentation notes that discontinuing the medicine suddenly, particularly after long-term use, can result in a rebound effect where the original symptoms (pain, inflammation) return or temporarily worsen. Official information states that Zetafen is not classified as a drug that causes classic withdrawal symptoms.


Q: Why do some people say they have trouble sleeping after starting Zetafen?

Regulatory documents list sleeplessness (insomnia) and agitation as reported, typically rare, nervous system side effects. Additionally, if the medicine is not providing adequate relief, the underlying symptoms of pain or discomfort could also be a source of sleep disruption.


Q: Can Zetafen cause changes in appetite or weight?

Adverse reaction reports from regulatory documents list decreased appetite and fluid retention as documented side effects. These effects may be noticed and can indirectly relate to temporary changes in weight or body perception.


Q: Is Zetafen linked to any known mental health or mood changes?

Official regulatory documents list rare reports of adverse reactions related to mental health and mood, including changes such as depression, agitation, and anxiety. In cases of overdose, the potential for more severe psychiatric symptoms like disorientation and hallucination is noted.


Q: What should I do if I think I've taken too much Zetafen?

If a person suspects that they have taken more than the maximum recommended amount, authoritative guidance states that calling the local emergency number or the Poison Control Center immediately is necessary for specific instructions.


Q: If I experience a rare side effect, is there a system for reporting it?

Yes. Official pharmacovigilance schemes exist, and reporting is recommended for suspected or rare side effects. Examples of these systems include the FDA MedWatch program in the United States or equivalent national reporting schemes.


Q: Are there certain foods or drinks I should avoid while using Zetafen?

Regulatory guidance advises avoiding heavy or chronic alcohol consumption while taking Zetafen, as this combination significantly increases the risk of serious gastrointestinal bleeding. The medicine may generally be taken with food or milk to reduce potential stomach discomfort.


Q: Can Zetafen be taken alongside herbal supplements like St. John's Wort?

Specific herbal products are often not listed individually in drug labels, but regulatory warnings emphasize caution. Many common herbal supplements can affect blood clotting or liver function, and regulatory warnings state that co-administration should be reviewed by a healthcare professional to rule out potential interactions.


Q: Can Zetafen interact with common anesthesia used in surgery?

Due to its effect on blood clotting (antiplatelet effect), Zetafen may need to be temporarily stopped prior to surgery or procedures that require anesthesia. This practice is based on general guidelines to reduce the risk of excessive bleeding complications.


Q: Does Zetafen show up on standard drug screening tests?

Zetafen is not an illicit substance, but consuming high doses of Ibuprofen has been associated with the potential for false positive results for certain prescription substances (such as barbiturates or benzodiazepines) on some standard urine drug screening tests.


Q: Does Zetafen change how other medicines are absorbed by the body?

Regulatory information indicates that Zetafen is known to affect the clearance (elimination rate) and increase the plasma levels of some co-administered drugs like Lithium and Methotrexate. Explicit statements detailing changes in absorption are typically not provided for all medicines in the labeling.


Q: How does my weight or body mass affect the way Zetafen works?

Regulatory dosing for children is strictly based on their body weight. For adults, while dosing is standardized, individual patient weight and body mass can influence how the medicine is distributed and metabolized in the body, potentially affecting its overall action.


Q: What are the main things I should discuss with my doctor before starting Zetafen?

Regulatory guidance strongly highlights key discussion points to ensure safe use. These include pre-existing medical conditions (especially heart, liver, or kidney problems), current co-administered medications (especially blood thinners), and any history of allergic reactions to NSAIDs or aspirin.


Q: Why is it important not to share Zetafen with someone else?

Regulatory guidance emphasizes that the safe use of Zetafen is based on individual factors like medical history, weight, and co-administered drugs. Sharing the medicine may result in serious side effects or a dangerous interaction for the other person due to inappropriate use.


Q: What is the shelf life of Zetafen, and how should I store it?

Regulatory instructions provide strict storage criteria, requiring that the medicine be kept at controlled room temperature and protected from light and excessive moisture. The official container will include an expiration date (shelf life) which indicates the time limit during which the manufacturer confirms the product’s full potency and safety.


Q: If I'm taking multiple medicines, how do I know if Zetafen is the problem if I feel unwell?

Because Zetafen has known interactions and potential side effects, any new or worsening symptoms often require evaluation by a healthcare professional to determine the cause and adjust the medicine regimen as needed.


Q: If I am sensitive to certain ingredients in medicine, what should I check in Zetafen?

While the active ingredient is Ibuprofen, the final product also contains inactive ingredients (excipients), which can vary greatly between manufacturers and formulations. Official regulatory labeling always includes a complete list of these ingredients, which patients may need to review against any known sensitivities or allergies.

How should Zetafen be stored and disposed of?

How to Store and Dispose of Zetafen?

The storage and disposal requirements for Zetafen (Ibuprofen) are defined by regulatory bodies to maintain the product's integrity and safety.

Storage Requirements

Zetafen must be stored at controlled room temperature, specifically between 20 C and 25 C (68 F and 77 F). The medicine must be kept in the original container, which should be tightly closed, and protected from light and excessive moisture. It is a mandatory requirement that the product must not be frozen.

Child Safety and Disposal

To prevent accidental poisoning, the medication must be kept out of the sight and reach of children. For disposal of unused or expired Zetafen, the official guidance directs use of a secure medicine take-back program. If this is unavailable, the drug should be mixed with an unappealing substance, sealed in a bag, and then discarded in the household trash. The product should not be flushed down the toilet.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Zetafen found in:

A-Z Index: